WPI MINOCYCLINE 75 (Minocycline 75 mg)
Pill imprint WPI MINOCYCLINE 75 has been identified as Minocycline hydrochloride 75 mg.
Minocycline is used in the treatment of acne; bacterial infection; rosacea; rheumatoid arthritis; skin or soft tissue infection (and more), and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 75 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- WPI MINOCYCLINE 75
- Strength:
- 75 mg
- Color:
- White & Yellow
- Size:
- 16.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Tetracyclines
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-3153
- Inactive Ingredients:
- magnesium stearate
corn starch
D&C Red No. 28
D&C Yellow No. 10
gelatin
silicon dioxide
sodium lauryl sulfate
titanium dioxide
More about minocycline
Consumer resources
- Minocycline
- Minocycline capsules
- Minocycline extended-release tablets
- Minocycline injection
- Minocycline microspheres
- More (3) »
- Other brands: Minocin, Solodyn, Dynacin, Cleeravue-M, More (2) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
